Hudson Bay Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-595,000
Closed -$11.2M 892
2024
Q1
$11.2M Sell
595,000
-330,200
-36% -$5.67M 0.06% 162
2023
Q4
$13.3M Buy
925,200
+111,100
+14% +$1.51M 0.08% 143
2023
Q3
$14.1M Buy
814,100
+159,100
+24% +$3.32M 0.11% 118
2023
Q2
$13.6M Buy
655,000
+65,000
+11% +$1.41M 0.1% 138
2023
Q1
$13.9M Buy
590,000
+345,000
+141% +$9.26M 0.11% 132
2022
Q4
$6.84M Sell
245,000
-30,000
-11% -$767K 0.07% 261
2022
Q3
$6.43M Buy
+275,000
New +$8.3M 0.06% 306
2022
Q1
Sell
-70,000
Closed -$2.13M 1279
2021
Q4
$2.13M Buy
70,000
+50,000
+250% +$1.63M 0.02% 658
2021
Q3
$656K Sell
20,000
-80,000
-80% -$2.56M 0.01% 790
2021
Q2
$3.03M Buy
+100,000
New +$3.29M 0.04% 503

Other funds holding OGN

Hudson Bay Capital Management's OGN Position: Q2 2024 in Review

Hudson Bay Capital Management sold out of Organon & Co (OGN) in Q2 2024, closing a stake of 595,000 shares — an estimated $11.2M sold.

Hudson Bay Capital Management first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $14.1M in Q3 2023. 724 funds tracked by Wall St. Rank hold OGN as of Q2 2024.

  • Hudson Bay Capital Management reported no remaining Organon & Co position as of Q2 2024 after selling out during the quarter.
  • Hudson Bay Capital Management sold 595,000 Organon & Co shares in Q2 2024, an estimated $11.2M.
  • Hudson Bay Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
  • Hudson Bay Capital Management's Organon & Co position peaked at $14.1M in Q3 2023.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q2 2024.

Based on Hudson Bay Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.